Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sulzer retains medical division in major restructuring

This article was originally published in Clinica

Executive Summary

The Swiss group, Sulzer, is to embark on the most extensive restructuring in its history. It will shed its traditional industrial units and concentrate on high-growth, profitable businesses, including its medical arm Sulzer Medica. It will also re-acquire the 26% share of subsidiary Sulzer Medica it does not already own, eliminating the "dual structure" of the company. The divestments will result in around SwFr1 billion ($563 million) to be ploughed back into the remaining businesses. Sulzer plans to spend over SwFr2 billion on acquisitions within two years.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074644

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel